Please login to the form below

Not currently logged in
Email:
Password:

CROS NT appoints Andrew MacGarvey to lead new UK office

Contract research organisation's new facility will be based in Milton Keynes

CROS NT Andrew MacGarveyItalian contract research organisation CROS NT has expanded into the UK and appointed Andrew MacGarvey to lead operations from its new facility in Milton Keynes.

MacGarvey has over 15 years' experience within the pharmaceutical sector and as CROS NT's new vice president of UK and USA operations he will be tasked with growing ties with the contract research organisation's UK-based customers.

MacGarvey previously held senior management and director roles at multiple contract research organisation (CROs) in Europe and the US.

"I have followed the activities of CROS NT for some time," MacGarvey said. "I am excited by the opportunity to help with the growth of the business. CROS NT are focused on customer care, something that is very important to me. I will be bringing their great service to the UK and ultimately the US."

Verona-headquartered CROS NT's new UK base joins its existing facilities in Italy and Augsburg, Germany.

17th August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Liberation Unlimited

'Progressive', 'cutting edge' – words used to describe Liberation Unlimited. We believe looking forward is essential to delivering successful and...

Latest intelligence

When forecasters take the floor: 6 tips on presenting a forecast
Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast...
Enablers of drug innovation could lie in the numbers
Christopher Ehinger of Black Swan Analysis addresses the problem of clinical-trial recruitment as a barrier to new drug development and offers a new way of looking at the problem....
Forecasting for Licensed Compounds
Peter Mansell examines the impact of heavier in-licensing/out-licensing traffic on pharmaceutical forecasting...

Infographics